(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO COM CONJUGADOS ANTICORPO-FÁRMACO ANTI-HER2 DE LOCAL ESPECÍFICO

ArquivadaInvention PatentPCT · IB2021057027
Talk to an expert

Application data

Number

112023002154

Type

Invention Patent

Filing

08/02/2021

Publication

03/14/2023

PCT

IB2021057027
View on INPI

Progress at the INPI

  1. Filing08/02/21
  2. Publication03/14/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 08/02/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/29/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PFIZER INC.

US

See this company's full portfolio

Inventors

S. W. (pessoa física)

US

Y. W. (pessoa física)

US

Technical data

IPC Classification

A61K 47/68A61P 35/00

Priority claims

US

63/060,873 · 08/04/2020

Abstract

TRATAMENTO COM CONJUGADOS ANTICORPO-FÁRMACO ANTI-HER2 DE LOCAL ESPECÍFICO. A presente invenção refere-se ao tratamento de pacientes com câncer pediátrico e/ou um câncer pediátrico que expressa HER2 com um conjugado anticorpo-fármaco anti-HER2 (ADC).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

10/29/2024

RPI 2808

Arquivamento - Art. 33 da LPI

#11.1

08/13/2024

RPI 2797

Notificação de entrada na fase nacional - PCT

#1.3

03/14/2023

RPI 2723

Alteração de dados cadastrais

#1.1

02/14/2023

RPI 2719

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.